期刊
ORAL ONCOLOGY
卷 105, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.oraloncology.2020.104652
关键词
Human papillomavirus; Oropharyngeal squamous cell carcinoma; Treatment; Deintensification; De-escalation; Review
Human papillomavirus (HPV)-related oropharyngeal squamous cell cancer (OPSCC) has emerged as a distinct clinical entity of head and neck cancer with expected high survival. This recognition has led to the investigation of whether a population of patients can be identified who can safely undergo treatment de-escalation, in an effort to minimize long-term treatment toxicity while maintaining excellent survival. The purpose of this review is to describe the rationale for treatment deintensification for HPV-related OPSCC, summarize available results from published clinical trials, explore the methods by which risk groups are assigned, and provide context for the multitude of clinical trials that are currently underway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据